ERL080 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
228閉塞性細気管支炎1

228. 閉塞性細気管支炎


臨床試験数 : 97 薬物数 : 118 - (DrugBank : 32) / 標的遺伝子数 : 33 - 標的パスウェイ数 : 156
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2004-001290-25-AT
(EUCTR)
14/07/200506/09/2005A 3-Year Randomised, Open Label, Multi-Centre Investigator Driven Study Comparing de Novo Enteric Coated Mycophenolate Sodium with Delayed Onset Everolimus, Both Arms in Combination with Cyclosporin (using C2 monitoring) and Corticosteroids for the Prevention of Bronchiolitis Obliterans Syndrome in Heart-Lung, Bilateral Lung and Single Lung Transplant Recipients. (CERL080A2415)A 3-Year Randomised, Open Label, Multi-Centre Investigator Driven Study Comparing de Novo Enteric Coated Mycophenolate Sodium with Delayed Onset Everolimus, Both Arms in Combination with Cyclosporin (using C2 monitoring) and Corticosteroids for the Prevention of Bronchiolitis Obliterans Syndrome in Heart-Lung, Bilateral Lung and Single Lung Transplant Recipients. (CERL080A2415) Patients between 18-65 years who have received either a single or bilateral lung transplant or a combined heart-lung transplant and who are suitable to receive triple immunosuppressive therapy with either mycophenolate sodium or everolimus, both arms in combination with cyclosporin and corticosteroids.Product Name: Myfortic
Product Code: ERL080
INN or Proposed INN: Mycophenolate
Trade Name: Certican 0,5 mg Tabletten
Product Name: Certican 0,5
Product Code: RAD001
INN or Proposed INN: Everolimus
Trade Name: Certican 0,75mg Tabletten
Product Name: Certican 0,75mg
Product Code: RAD001
INN or Proposed INN: Everolimus
Prof Allan Glanville, St Vincents HospitalNULLNot RecruitingFemale: yes
Male: yes
320Spain;Austria;Germany;United Kingdom